CodaVax-RSV

BIOLOGICAL2 trials

Sponsors

Codagenix, Inc

Conditions

Respiratory Syncytial Virus Infections

Phase 1

Safety and Immunogenicity of a Live-attenuated Vaccine Against Respiratory Syncytial Virus in Elderly Volunteers

CompletedNCT04295070

Codagenix, IncRespiratory Syncytial Virus Infections

Start: 2020-07-10End: 2021-05-26Updated: 2021-06-10

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

TerminatedNCT04919109

Codagenix, IncRespiratory Syncytial Virus Infections

Start: 2023-03-28End: 2026-07-08Updated: 2026-07-15